Intra-cellular Therapies, Inc. (ITCI)
$67.88
Intra-cellular Therapies, Inc. (ITCI) Share Price Forecast
Currently 23 wall-street analysts regularly analyze the financials of Intra-cellular Therapies, Inc. on a frequent basis to provide recommendations along with target share price. 23 analysts offering 12-month price forecasts for Intra-cellular Therapies, Inc. (ITCI) have a share price target of $91.64. This median of share price forecast represents a 35% upside from the latest price of $67.88 as on 05.06.24.
Intra-cellular Therapies, Inc. (ITCI) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Intra-cellular Therapies, Inc. (ITCI) share price will touch around $91.64 in next 12-months.
Intra-cellular Therapies, Inc. (ITCI) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Intra-cellular Therapies, Inc.'s share price and its median forecast price. As on 05.06.24, the difference is -20.64%
Intra-cellular Therapies, Inc. (ITCI): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Intra-cellular Therapies, Inc. (ITCI) Share Price : Analyst Recommendation
Based on 23 analysts tracking and researching Intra-cellular Therapies, Inc. (ITCI) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 14 | 13 | 14 |
| Outperform | 6 | 6 | 6 |
| Hold | 3 | 3 | 3 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
Intra-cellular Therapies, Inc. (ITCI) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Intra-cellular Therapies, Inc. (ITCI) is $91.64, offered by 23 analysts offering 12-month price forecasts.
Intra-cellular Therapies, Inc. (ITCI) has a maximum of 0.35 upside potential, based on 23 analysts offering 12-month price forecasts.
Based on 23 analysts tracking and researching Intra-cellular Therapies, Inc. (ITCI), 86.96% have a buy recommendation. Remaining 13.04% have either sell or hold recommendations.
The latest share price of Intra-cellular Therapies, Inc. (ITCI) is $67.88 as of 05/06/2024.
20 of total 23 analysts offering stock ratings for Intra-cellular Therapies, Inc. ITCI have recommended buy rating.
â‚ą0 US Stocks a/c Opening Fee